Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.

PubWeight™: 0.78^‹?›

🔗 View Article (PMID 25907350)

Published in Psychiatry Clin Neurosci on June 01, 2015

Authors

Naghmeh Mokhber¹, Amir Azarpazhooh²^,3^,4, Elias Orouji⁵, Bita Khorram⁵, Morteza Modares Gharavi¹, Sorayya Kakhi⁵, Hoda Khallaghi⁵, Mahmoud Reza Azarpazhooh⁵

Author Affiliations

1: Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
2: Department of Biological and Diagnostic Sciences, Faculty of Dentistry, University of Toronto, Toronto, Canada.
3: Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Canada.
4: Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Canada.
5: Department of Neurology, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Articles citing this ↘

A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study. Neurol Sci (2017) 0.75

Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs. CNS Drugs (2017) 0.75

Articles by these authors ⇆

Cerebral vein thrombosis in women using short course oral contraceptive consumption. Iran J Reprod Med (2012) 0.82

Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: a randomized clinical trial. J Neurol Sci (2014) 0.78

Microembolic signals in patients with systemic lupus erythematosus. Can J Neurol Sci (2010) 0.78

Mental health status following severe sulfur mustard exposure: a long-term study of Iranian war survivors. Asia Pac Psychiatry (2016) 0.75